Jaguar Health, Inc. (JAGX)
2.91
-0.56
(-16.14%)
USD |
NASDAQ |
May 22, 16:00
3.10
+0.19
(+6.53%)
After-Hours: 20:00
Jaguar Health EPS Diluted (Quarterly) : -116.40 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Jupiter Neurosciences, Inc. | -0.0585 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Johnson & Johnson | 2.141 |
| Eli Lilly & Co. | 8.255 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.19M |
| Revenue (Quarterly) | 3.235M |
| Total Expenses (Quarterly) | 26.30M |
| Enterprise Value | 37.94M |
| Gross Profit Margin (Quarterly) | 15.21% |
| Profit Margin (Quarterly) | -716.9% |
| Earnings Yield | -24.46K% |
| Normalized Earnings Yield | -20446.40 |